JBF Capital, Inc. - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 1 filers reported holding AMRYT PHARMA PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JBF Capital, Inc. ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$1,093,50075,0000.25%
Other shareholders
AMRYT PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 765,236$9,458,0009.84%
Global Frontier Investments LLC 125,000$1,545,0002.28%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 676,034$8,281,0000.45%
EdgePoint Investment Group Inc. 2,293,180$28,344,0000.32%
Context Partners Fund, L.P. 69,437$858,0000.19%
Context Capital Management, LLC 69,437$858,0000.19%
WHITEBOX ADVISORS LLC 271,624$3,341,0000.14%
ARMISTICE CAPITAL, LLC 306,000$3,782,0000.14%
AMERIPRISE FINANCIAL INC 716,895$8,817,0000.00%
Tower Research Capital LLC (TRC) 302$4,0000.00%
View complete list of AMRYT PHARMA PLC shareholders